Track topics on Twitter Track topics that are important to you
Molecular diagnostics company Atonarp has raised $33m (£26.8m) in the Series C funding round that saw the participation of five new investors. In an oversubscribed series C funding
The post Molecular diagnostics firm Atonarp secures £26.8m in Series C funding appeared first on NS Medical Devices.
Original Article: Molecular diagnostics firm Atonarp secures £26.8m in Series C fundingNEXT ARTICLE
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...